Canada \u00b7 BC coverage
Is Ozempic covered in BC? What PharmaCare actually covers.
“Is Ozempic covered in BC?” is one of the most-searched GLP-1 questions in British Columbia. The short answer: yes for type 2 diabetes, with Special Authority; no for weight loss. Wegovy and Mounjaro are not PharmaCare benefits. Below is what BC's own documents say, with links so you can check them yourself.
Last reviewed October 15, 2026against Health Canada's Drug Product Database and BC PharmaCare documents.
GLP-1 coverage in BC at a glance
| Medicine | Used for | BC PharmaCare status |
|---|---|---|
| Ozempic and generic semaglutide injection | Type 2 diabetes | Limited Coverage (Special Authority); highest-strength pen non-benefit |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Non-benefit |
| Mounjaro (tirzepatide) | Type 2 diabetes | Non-benefit |
| Trulicity (dulaglutide) | Type 2 diabetes | Non-benefit |
| Victoza (liraglutide) | Type 2 diabetes | Non-benefit |
| Wegovy | Weight management | Non-benefit (decision December 18, 2025) |
Diabetes rows: BC's September 2026 type 2 diabetes drug table. Wegovy: the PharmaCare coverage decision.
The Special Authority criteria for Ozempic
PharmaCare's Special Authority request form for semaglutide (HLTH 5826, revised February 2026) gives indefinite coverage when both are true:
- The patient has a diagnosis of type 2 diabetes, and
- Blood-sugar control was inadequate on the highest dose of metformin they could tolerate (the prescriber can explain why metformin was avoided).
The prescriber submits the form; patients can't apply themselves. PharmaCare won't cover a DPP-4 inhibitor (linagliptin or saxagliptin) at the same time: approving one ends coverage of the other. What you actually pay still depends on your PharmaCare plan and deductible.
Why Wegovy isn't covered in BC
Canada's Drug Agency recommended public coverage of Wegovy only for adults with a BMI of 27 or more and established cardiovascular disease (a prior heart attack, stroke or peripheral artery disease), and only with a price reduction. The pan-Canadian Pharmaceutical Alliance then ended negotiations without an agreement because the manufacturer declined, so BC made Wegovy a non-benefit on December 18, 2025. More: Is Wegovy covered in Canada?
Private plans and other options
- Workplace and private plans set their own rules; some cover Ozempic, Wegovy or Mounjaro. Check your plan booklet or ask the insurer.
- Plans often prefer a generic semaglutide once one is listed. Ask your pharmacist.
- “Research” semaglutide sold online isn't covered by anything because it isn't an authorized drug: see Health Canada's April 2026 advisory.
What semaglutide users report
- 37 published anonymous semaglutide confessions; 5 mention at least one side effect.
- 12 mention Ozempic, Wegovy or Rybelsus by name.
- Among confessions that state a weight change in pounds, the median reported is 50 lb. Self-reported, unverified.
Most-mentioned side effects (share of semaglutide confessions):
- Burping: 5.4% (2)
- Nausea: 5.4% (2)
- Vomiting: 5.4% (2)
- Anxiety or panic: 2.7% (1)
- Constipation: 2.7% (1)
Counts are phrase mentions in anonymous accounts, not diagnoses or clinical rates. Full breakdown and methodology: semaglutide side-effects report.
By province and city
Related
Frequently asked questions
- Is Ozempic covered in BC?
- Yes, for some people. BC PharmaCare lists semaglutide injection (Ozempic and its generics) as a Limited Coverage benefit. A prescriber must get Special Authority showing type 2 diabetes and inadequate blood-sugar control on the highest tolerated dose of metformin.
- Does BC PharmaCare cover Ozempic for weight loss?
- No. The Special Authority criteria are for type 2 diabetes only. PharmaCare does not cover semaglutide for weight management.
- Is Wegovy covered in BC?
- No. BC PharmaCare made Wegovy a non-benefit on December 18, 2025, after the pan-Canadian Pharmaceutical Alliance ended negotiations without an agreement (the manufacturer declined to negotiate).
- Is Mounjaro covered in BC?
- Not by PharmaCare. BC's September 2026 diabetes drug table lists Mounjaro (tirzepatide) as a non-benefit. Some private plans cover it.
- Are all Ozempic pens covered?
- BC's September 2026 drug table lists semaglutide injection as Limited Coverage, with the highest-strength pen listed as a non-benefit. Your pharmacist can tell you which pen your coverage applies to.
- Does this page recommend a clinic, product or dose?
- No. We don't list clinics, sellers, prices or doses, and nothing here is medical advice. Talk to a licensed BC prescriber or pharmacist.
Sources
- BC PharmaCare Special Authority request: semaglutide for diabetes, HLTH 5826 (gov.bc.ca)
- BC Provincial Academic Detailing: type 2 diabetes drug table, September 2026 (gov.bc.ca)
- BC PharmaCare drug coverage decision: Wegovy, December 18, 2025 (gov.bc.ca)
- BC PharmaCare Special Authority program (gov.bc.ca)
- Drug Product Database (health-products.canada.ca)
General information only — not medical, legal or regulatory advice. Peptide Confessions does not sell, source or recommend any product or vendor, and nothing here is dosing guidance. Speak with a licensed Canadian healthcare professional or pharmacist about any medication. Editorial process →